Please assess the completion status of the following clinical trial:

Trial Title: Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
* INCLUSION CRITERIA:~  1. Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2~ 2. Pathology report confirming adenocarcinoma of the prostate~ 3. Risk of lymph node metastasis less than 10% as defined by the Partin tables~ 4. Tumor visible on magnetic resonance imaging (MRI)~ 5. No prior surgery, radiation, or chemotherapy for prostate cancer.~ 6. Age greater than 18 y/o and less than 90 years old.~EXCLUSION CRITERIA:~1. Cognitively impaired patients who cannot give informed consent.~2. Patients with metastatic disease.~3. Contraindication to biopsy~   * Bleeding disorder~  * Prothrombin time (PT)/Partial Thromboplastin Time (PTT) greater than or equal to 1.5 times the upper limit of normal~  * Platelets less than or equal to 50K~  * Artificial heart valve~4. Contraindication to magnetic resonance imaging (MRI)~   * Patients weighing greater than 136 kgs (weight limit for the scanner tables)~  * Allergy to MR contrast agent~  * Patients with pacemakers, cerebral aneurysm clips, shrapnel injury or implantable electronic devices.~5. Pre-existing and active prostatitis or proctitis~6. Other medical conditions deemed by the principal investigator (PI) or associates to make the patient ineligible for protocol investigations, procedures, and high-dose external beam radiotherapy.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Radiation Therapy (Type: EXPERIMENTAL): Radiation to tumor area as per protocol

Based on this trial design, predict the completion outcome and termination type (if applicable).